Syros Pharmaceuticals | 4:持股變動聲明-董事 Simonian Nancy A
Syros Pharmaceuticals | 4:持股變動聲明-董事 Simonian Nancy A
Syros Pharmaceuticals | 4:持股變動聲明-高管 Haas Jason
Syros Pharmaceuticals | 4:持股變動聲明-高管 Chee Conley
Syros Pharmaceuticals | 4:持股變動聲明-高管 Quirk Gerald E
Syros Pharmaceuticals | 4:持股變動聲明-高管 Roth David
Syros Pharmaceuticals | 4:持股變動聲明-高管 Stephens Kristin
Syros Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Avidity Partners Management LP(9.9%),Avidity Partners Management (GP) LLC(9.9%)等
Syros Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Bain Capital Life Sciences Fund II, L.P.(9.99%)
Syros Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Blue Owl Capital Holdings LP(1.92%)
Syros Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Invus Public Equities, L.P.(9.9%),Invus Public Equities Advisors, LLC(9.9%)等
Syros Pharmaceuticals | 4:持股變動聲明-高管 Stephens Kristin
Syros Pharmaceuticals | 4:持股變動聲明-高管 Chee Conley
Syros Pharmaceuticals | 4:持股變動聲明-高管 Haas Jason
Syros Pharmaceuticals | 4:持股變動聲明-高管 Roth David
Syros Pharmaceuticals | 4:持股變動聲明-董事 Simonian Nancy A
Syros Pharmaceuticals | 4:持股變動聲明-高管 Quirk Gerald E
Syros Pharmaceuticals | 4:持股變動聲明-董事 AKKARAJU SRINIVAS
Syros Pharmaceuticals | 4:持股變動聲明-董事 Young Richard A
Syros Pharmaceuticals | 4:持股變動聲明-高管 Chee Conley